Advancing Diagnostics for Patients with Neurological Disorders
Future Products & Concepts
Neurolign’s next-generation systems are designed to seamlessly capture and share high-fidelity eye movement data with medical professionals for interpretation.
Neurolign is continually improving Dx-100 hardware and plans to introduce a second-generation system. The Dx-200 is a head mounted goggle (HMI) with high-speed eye tracking system using a dual camera approach and a high-resolution display. Dx-200 will provide visual and auditory stimuli to patients through HMI and tracks. The device will seamlessly record and share eye movement data with medical professionals for interpretation.
Proposed System Features
QCS 610 Based SoM, running Android IOT
Wireless Joystick (Option for wired)
Status Lights and Single Button on Outside
USB-C Port for DFU, and tethered usage
Single Display (HD)
Speakers for Auditory instructions
Photo diode to synchronize display to camera
Dual camera simultaneous capture at 250FPS (one per eye)
Mechanics to Align Camera with eyes (no hot mirrors)
Neurolign utilizes industry-leading eye-tracking technology and expertise in neuroscience to develop innovative products that aid in the diagnosis and monitoring of neurological injury and disease.
Neurolign has developed a comprehensive battery of oculomotor, vestibular, reaction time, and cognitive (OVRT-C) tests delivered via the Neurolign Dx-100, our high-resolution eye-tracking goggle set. Together, results of these tests can reveal the unique and quantifiable patterns of OVRT-C deficits characteristic of specific neurological injuries or diseases.
Our multimodal method of OVRT-C testing makes us uniquely positioned to develop adjunctive tools with which to diagnose and monitor a number of these conditions and potentially contribute to patient recovery. Below, we share results from recent studies that highlight the efficacy of our novel approach to help clinicians diagnose and treat patients.
Diagnostics in Development
Neurolign is developing algorithms to identify patients with a variety of disorders with significant unmet diagnostic needs.
- Kelly K, Anghinah R, Kullmann A Oculomotor, vestibular, reaction time, and cognitive (OVRT-C) tests as objective measures of neural deficits in patients post COVID-19 infection. Frontiers in Neurology. 202210.3389/fneur.2022.919596.
- Kullmann A, Ashmore RC, Braverman A, et al. Portable eye-tracking as a reliable assessment of oculomotor, cognitive and reaction time function: normative data for 18-45 year old. PloS ONE. 2021;16(11):e0260351.
- Kullmann, A, Ashmore RC, Braverman A, et al. Normative data for ages 18-45 for ocular motor and vestibular testing using eye tracking. Laryngoscope Investigative Otolaryngology. 2021;6:1116-1127.
- Balaban CD, Szczupak M, Kiderman A, et al. Distinctive convergence eye movements in an acquired neurosensory dysfunction. Frontiers in Neurology. 2020;11:469.
- Kiderman A, Hoffer M, Szczupak M, et al. Oculomotor, vestibular, reaction time and cognitive eye-tracking mild traumatic brain injury assessment. Neurology. 2020;95(20 Supplement 1):S2.
- Balaban CD, Kiderman A, Szczupak M, et al. Patterns of pupillary activity during binocular disparity resolution. Frontiers in Neurology. 2018;9:990.
- Kelly KM, Kiderman K., Akhavan S., et al. Oculomotor, vestibular, and reaction time effects of sports-related concussion: video-oculography in assessing sports-related concussion. J Head Trauma Rehabil. 2018;34(3):176-188.
American Academy of Neurology 2022 | Seattle, WA
- Oculomotor, vestibular, reaction time, and cognitive assessment in vestibular migraine
Neuroscience 2021 | Chicago, IL
American Balance Society 2020 | Scottsdale, AZ
- Oculomotor, vestibular, reaction time and cognitive (OVRT-C) tests in recovered COVID-19 patients
A Quantum Shift in Brain Health and Wellness
Neurolign is on a mission to create a quantum shift in the clinical approach to neurodegenerative disease while simultaneously revolutionizing brain health and wellness.